Encompass Health Corp/ US29261A1007 /
| 04.06.2024 21:59:05 | Diff. +1,01 | Volumen | Geld22:25:01 | Brief22:25:01 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 84,57USD | +1,21% | 25.137 Umsatz: 883.147,51 |
-Geld Vol: - | -Brief Vol: - | 8,51 Mrd.USD | 0,71% | 24,07 |
Aktiva
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 1.634,8000 | 1.959,3000 | 2.206,6000 | 2.601,6000 | 2.939,2000 | ||||||
| Immaterielle Vermögensgegenstände | 443,4000 | 476,3000 | 431,3000 | 417,5000 | 282,3000 | ||||||
| Finanzanlagen | - | - | - | - | - | ||||||
| Anlagevermögen | 4.512,9000 | 5.324,9000 | 5.497,3000 | 5.943,5000 | 4.919,3000 | ||||||
| Vorräte | - | - | - | - | - | ||||||
| Forderungen | 467,7000 | 506,1000 | 572,8000 | 680,3000 | 536,8000 | ||||||
| Liquide Mitteln | 69,2000 | 94,8000 | 224 | 54,8000 | 21,8000 | ||||||
| Umlaufvermögen | 662,1000 | 755,8000 | 948,6000 | 921,4000 | 717,2000 | ||||||
| Aktiva, gesamt | 5.175 | 6.080,7000 | 6.445,9000 | 6.864,9000 | 5.636,5000 | ||||||
Passiva
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 90 | 94,6000 | 115 | 137,6000 | 132,9000 | ||||||
| Langfristige Schulden | 2.478,6000 | 3.023,3000 | 3.250,6000 | 3.243,9000 | 2.741,8000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 2.478,6000 | 3.023,3000 | 3.250,6000 | 3.243,9000 | - | ||||||
| Rückstellungen | - | - | 51,8000 | 86,7000 | - | ||||||
| Verbindlichkeiten | 3.618 | 4.387,6000 | 4.475,9000 | 4.507,9000 | 3.810,2000 | ||||||
| Gezeichnetes Kapital | 1,1000 | 1,1000 | 1,1000 | 1,1000 | 1,1000 | ||||||
| Eigenkapital | 1.557 | 1.693,1000 | 1.970 | 2.357 | 1.826,3000 | ||||||
| Minderheitenanteile | 280,3000 | 340,9000 | 382 | 445,7000 | 516 | ||||||
| Passiva, gesamt | 5.175 | 6.080,7000 | 6.445,9000 | 6.864,9000 | 5.636,5000 | ||||||
Gewinn- und Verlustrechnung
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 4.277,3000 | 4.605 | 4.644,4000 | 5.121,6000 | 4.348,6000 | ||||||
| Abschreibungen (Gesamt) | 199,7000 | 218,7000 | 243 | 256,6000 | 243,6000 | ||||||
| Betriebsergebnis | - | - | - | - | - | ||||||
| Zinsergebnis | 147,3000 | 159,7000 | 184,2000 | 164,6000 | 175,7000 | ||||||
| Ergebnis vor Steuern | 493,2000 | 562,3000 | 472,6000 | 657,2000 | 450,8000 | ||||||
| Ertragsteuern | 118,9000 | 115,9000 | 103,8000 | 139,6000 | 100,1000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | -83,1000 | -87,1000 | -84,6000 | -105 | -94,9000 | ||||||
| Konzernjahresüberschuss | 292,3000 | 358,7000 | 284,2000 | 412,2000 | 271 | ||||||
Pro Aktie
Cash Flow
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 762,4000 | 635,3000 | 704,7000 | 715,8000 | 705,8000 | ||||||
| Cash Flow aus Investitionstätigkeit | -424,5000 | -657,4000 | -407,5000 | -666,3000 | -627 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -321,2000 | 48,2000 | -145,9000 | -240,1000 | -145,7000 | ||||||
| Veränderung der liquiden Mittel | 16,7000 | 26,1000 | 151,3000 | -190,6000 | -66,9000 | ||||||
| Anzahl der Mitarbeiter | 30.060 | 31.570 | 43.178 | 43.400 | - | ||||||
